Compare DAL & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAL | A |
|---|---|---|
| Founded | 1924 | 1999 |
| Country | United States | United States |
| Employees | 78400 | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.2B | 38.0B |
| IPO Year | 2004 | 1999 |
| Metric | DAL | A |
|---|---|---|
| Price | $91.55 | $145.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 15 |
| Target Price | $79.26 | ★ $161.47 |
| AVG Volume (30 Days) | ★ 6.1M | 1.7M |
| Earning Date | 04-08-2026 | 05-27-2026 |
| Dividend Yield | ★ 1.13% | 0.92% |
| EPS Growth | ★ 43.71 | 3.16 |
| EPS | 2.00 | ★ 2.27 |
| Revenue | ★ $41,244,000,000.00 | $4,472,000,000.00 |
| Revenue This Year | $3.47 | $8.45 |
| Revenue Next Year | $3.97 | $6.13 |
| P/E Ratio | ★ $45.99 | $62.27 |
| Revenue Growth | N/A | ★ 6.43 |
| 52 Week Low | $53.12 | $108.35 |
| 52 Week High | $95.68 | $160.27 |
| Indicator | DAL | A |
|---|---|---|
| Relative Strength Index (RSI) | 60.20 | 62.69 |
| Support Level | $64.41 | $141.22 |
| Resistance Level | $95.68 | $151.38 |
| Average True Range (ATR) | 2.23 | 3.68 |
| MACD | 0.63 | 0.19 |
| Stochastic Oscillator | 78.91 | 93.86 |
Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke network, where it gathers and distributes passengers across the globe through its biggest hubs in Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta has historically earned most of its international revenue and profits from flying passengers over the Atlantic Ocean.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.